Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.
about
Is increased antidepressant exposure a contributory factor to the obesity pandemic?Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunctionThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Cardiovascular risk may be increased in women with unexplained infertilityDifferential activation of endocrine-immune networks by arthritis challenge: Insights from colony-specific responsesDepressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: a pilot study.Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder.Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.Depression, cytokines, and pancreatic cancerHealth surveillance of deployed military personnel occasionally leads to unexpected findings.Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorderPeripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy.The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohortVulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.Subfertility and risk of later life maternal cardiovascular disease.Pain-related anxiety mediates the relationship between depressive symptoms and pain interference in veterans with hepatitis C.The adaptive neuroplasticity hypothesis of behavioral maintenance.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.An investigation into the effects of antenatal stressors on the postpartum neuroimmune profile and depressive-like behaviorsEvidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression.TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Risk factors for the development of depression in patients with hepatitis C taking interferon-α.A neuroimmunological perspective on anxiety disorders.Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics.Towards translational rodent models of depression.Research review: the role of cytokines in depression in adolescents: a systematic review.The potential role of monocyte chemoattractant protein-1 for major depressive disorder.Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression.Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.Molecular hydrogen increases resilience to stress in mice.The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
P2860
Q26765430-129794F6-79FD-46C8-B6FB-0E889C9DFD18Q27024383-2BCFE56F-6CE5-41AD-B0A3-A567A325ECD0Q28300843-9C7F6B5C-215F-46AE-8551-EF40CA465F71Q30372214-23B3EE51-A9FE-4AE3-BDE7-9D911509CF67Q30476952-BA562295-C3CA-4464-AD0E-BCB027B62CC1Q33575570-D35EA13B-56F5-4ADD-994E-D6933AD07680Q33673998-57F9E950-446E-40DC-B192-285B96101549Q33986214-BA833A63-E974-41CD-8CBC-8BBC33D3176CQ34020859-0139B610-F926-4CE9-8CB5-9526DFFDAE15Q34137925-7F363892-91E5-434B-A4A5-00428374C9B2Q34453593-FA651457-4DA5-4429-98E4-272BE4DEE029Q34457085-6BE05F4E-CB91-462C-9A84-C2A775FA13AFQ34631833-D1C2540F-4E95-416C-9A43-8B313F2BA928Q34843459-65816BE8-4312-4C2B-AA5D-42DF276DA866Q35169186-60E5B3C5-1FA4-460F-8EBF-594E731B029DQ35203734-86733529-FF22-407C-A3F8-885AC17DC4A7Q35424733-31A6BB9F-3847-43D5-AAF6-64855FB63FC8Q35535322-3B18269D-4C58-4741-B803-57D073177EEAQ35535351-CBFB8766-DB29-4E6C-93DB-3DE950A9ED7EQ35767946-8959BE20-65F9-4D89-B253-5BFBC85E3F66Q36240463-D91BE781-1202-4567-92EC-08E673DE1A57Q36344187-727239B6-C750-45F4-BDE0-E31781910271Q36381738-D90144CE-3139-4BFF-8D15-5645DD40FE43Q36384392-23D2B456-8139-49DF-AE3C-B4B8C937B08DQ36395733-ED5D7FCA-EB30-4C4F-8F0F-D53B1C590821Q36589656-472C5F4C-7FE4-425D-BDA4-9005A1C62B6DQ37254527-39828147-09FC-4AD8-842B-8ECDB18AA0EAQ37349893-746A303B-117A-4FD4-B673-2442F7FDC93BQ37668003-97EBDD00-71C4-44B6-96DE-B5198FEC0CDFQ37886673-AF089945-FB5A-444E-B2BB-F2C208324CD4Q37972855-C0BDFC37-4AC9-4B88-9B57-841387771ACEQ38015254-E9A56DCD-8380-48CE-B21F-B5337B4F86DDQ38092709-D9999D3E-4FA9-4B8A-98C9-6948FD11F696Q38136672-634AAE03-9F78-4DE1-A7CA-AEA7199F8991Q38238754-135DCF3C-C4E4-4CFF-9504-E63956E4A0F3Q38901511-5AB8F56F-47E0-4E7F-9D9F-504EE93DF461Q39183229-A3253F87-74D8-4FA2-9084-6AD954BEA359Q39311969-739A64B9-2325-47DA-9377-7F6931579A96Q39417618-FE12C31E-27B3-46F5-AC9E-2F1D79B883B6Q40156599-CEFC66B0-667E-4F24-B61B-C7D9089A4CD2
P2860
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@ast
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@en
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@nl
type
label
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@ast
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@en
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@nl
prefLabel
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@ast
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@en
Neuroimmune mechanisms of cyto ...... nd novel treatment strategies.
@nl
P2860
P1476
Neuroimmune mechanisms of cyto ...... and novel treatment strategies
@en
P2093
Benjamin J Morasco
Marilyn Huckans
P2860
P304
P356
10.1016/J.NBD.2009.11.015
P577
2009-11-26T00:00:00Z